targeted cancer drug
Interviews and expert commentary tagged “targeted cancer drug” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer.
AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to c
19 November 2013
0:00